vitrolife产品代理
vitrolife产品代理
2021年，Vitrolife收购了成立于2011年的IVF诊所女性健康和生殖基因检测服务领导者Igenomix。
我们共同打造了生殖健康领域的全球领导者，通过将 Igenomix 的生殖基因检测服务组合与 Vitrolife 一流的 IVF 设备组合相结合，我们将能够在整个生育过程中更好地支持诊所和患者。
Oocyte retrieval needles
Sperm processing
IVF media & oil
Micromanipulation pipettes
Labware
Benchtop incubators
Time-lapse systems & Evaluation tools
Genomics
Cryopreservation
Laser & imaging systems
Vitrolife is committed to supporting successful treatment outcomes, through a focus on IVF and the needs of clinics and testing labs. We’ve been dedicated to IVF since 1994, when the field was still young. Today, we support customers worldwide - always with sustainability in mind. Vitrolife Group has approximately 1200 employees and the headquarter is located in Sweden with additional locations and production facilities in more than 20 countries world-wide.
In 2021, Vitrolife acquired Igenomix which is a leader in women’s health and reproductive genetic testing services for IVF clinics, founded in 2011.
Together we create a global leader in reproductive health and by combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we will be able to better support clinics and patients across the fertility journey.
